Home > Insider Trading > Filing (0001161697-22-000574)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369568	Catalyst Pharmaceuticals Inc.	CPRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1279473	Gary Ingenito	355 Alhambra Circle, Suite 801 Coral Gables FL 33134	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2022-12-06	14,667	$0.00	36,720	No	4	M	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2022-12-06	5,918	$16.85	30,802	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2022-12-06	14,667	$0.00	14,667	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
914,000			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Dr. Ingenito sold the shares on the open market to pay for taxes due on the vesting of the restricted stock units and not as a result of any disagreement with the Registrant. Dr. Ingenito remains an officer of the Company.
Derivative securities vested in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 6, 2022.